Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

7.1%

18 terminated/withdrawn out of 254 trials

Success Rate

90.1%

+3.6% vs industry average

Late-Stage Pipeline

4%

9 trials in Phase 3/4

Results Transparency

26%

43 of 164 completed trials have results

Key Signals

33 recruiting43 with results11 terminated7 withdrawn

Enrollment Performance

Analytics

N/A
170(79.4%)
Phase 2
21(9.8%)
Phase 1
8(3.7%)
Early Phase 1
6(2.8%)
Phase 3
6(2.8%)
Phase 4
3(1.4%)
214Total
N/A(170)
Phase 2(21)
Phase 1(8)
Early Phase 1(6)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (254)

Showing 20 of 254 trials
NCT07539649Not ApplicableNot Yet Recruiting

LiveWell mBc: Adapted Dialectical Behavioral Therapy Skills Training

Role: collaborator

NCT00489307Phase 2Active Not Recruiting

Dexamethasone for Symptom Burden in Advanced Cancer Patients

Role: collaborator

NCT03955627Not ApplicableCompleted

REJOIN Trial for Older Breast Cancer Survivors

Role: collaborator

NCT03157323Not ApplicableActive Not Recruiting

Low GI Diet in Children and Adolescents With ALL

Role: collaborator

NCT05034289Not ApplicableCompleted

Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy

Role: collaborator

NCT07086833Not ApplicableRecruiting

The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities

Role: collaborator

NCT05385965Not ApplicableCompleted

Meaning-Centered Pain Coping Skills Training for Cancer Pain

Role: collaborator

NCT07332312Not ApplicableRecruiting

A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Indian and Alaska Native Cancer Patients Living in Rural California

Role: collaborator

NCT06635005Not ApplicableCompleted

A Low-Insulinemic Dietary Intervention to Reduce Breast Cancer Risk in High-Risk Women

Role: collaborator

NCT06085560Not ApplicableEnrolling By Invitation

Choose It and Use It: Choice, Implementation Intentions and At-Home Colorectal Cancer Screening

Role: collaborator

NCT04414540Phase 2Active Not Recruiting

Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients

Role: collaborator

NCT06728072Phase 2Recruiting

Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

Role: collaborator

NCT07265739Phase 2Not Yet Recruiting

Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer

Role: collaborator

NCT07504835Not ApplicableRecruiting

GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer

Role: collaborator

NCT07454330Not ApplicableRecruiting

Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors

Role: collaborator

NCT06671730Not ApplicableRecruiting

Self-Determination Theory-informed Occupational Therapy Program to Increase Physical Activity Among Survivors of Breast Cancer

Role: collaborator

NCT02526368Early Phase 1Recruiting

Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer

Role: collaborator

NCT00760656Recruiting

Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer

Role: collaborator

NCT03207958Phase 1Completed

Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation

Role: collaborator

NCT05497024Recruiting

Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing

Role: collaborator